Latest News and Press Releases

SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) -- Sun Genomics, creator of Floré, the world’s only fully customized precision probiotic, announced today that its founder and CEO, Sunny Jain, will be...

SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sun Genomics, creator of Floré, the world’s only fully customized precision probiotic, announced today it is expanding its gut health test options for...

SAN DIEGO and FRIBOURG, Switzerland, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Sun Genomics, the world’s only fully customized precision probiotic company, in collaboration with The Swiss Integrative Center...

SAN DIEGO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Sun Genomics, the direct-to-consumer custom probiotics and gut health company, announces the launch of its at-home Floré Labs COVID-19 Stool Test,...

SAN DIEGO, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Sun Genomics, syarikat probiotik tersuai terus kepada pengguna dan syarikat kesihatan usus, hari ini mengumumkan penutupan sejumlah $9.25 juta dalam...

샌디에이고,, Sept. 17, 2020 (GLOBE NEWSWIRE) -- 소비자 직접 서비스 형태의 맞춤형 프로바이오틱스 및 장 건강 제품 제조사인 Sun Genomics는 925만 달러 규모의 Series A 펀딩을 종료한다고 발표했다. Pangaea Ventures가 주도한 이번 라운드에서는 Orion Fund가 신규 투자를 단행했으며 K3...

サンディエゴ発 , Sept. 17, 2020 (GLOBE NEWSWIRE) -- 直販 (D2C) のカスタムプロバイオティクスおよび健腸に特化する企業サンゲノミクス (Sun Genomics) は本日、925万ドル (約9億7,125万円) のシリーズA資金調達の完了を発表した。今回のラウンドは、パンゲアベンチャーズ (Pangaea Ventures) が主導し、K3ベンチャーズ...

聖地牙哥, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Sun Genomics 是一家直接為消費者定制益生菌及腸道健康公司，今天宣佈完成 925 萬美元的 A 輪融資。這輪融資由 Pangaea Ventures 領導，並擁有由 K3 Ventures 及 Emerging Technologies Partners 管理的 Orion Fund...

圣迭戈, Sept. 17, 2020 (GLOBE NEWSWIRE) -- 面向消费者直营的定制益生菌和肠道健康公司Sun Genomics今天宣布完成了925万美元的A轮融资。该轮融资由Pangaea Ventures领投，新投资来自由K3 Ventures管理的Orion Fund和Emerging Technologies Partners。其他投资方包括Danone...

SAN DIEGO, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Sun Genomics, the direct-to-consumer custom probiotics and gut health company, announced today the close of $9.25 million in Series A funding. The round...